Ovid Therapeutics Inc. (OVID) Insider Trading

Name: Ovid Therapeutics Inc. (OVID) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 8, 2026): Carter Charles Ross (Chief Financial Officer): Grant/Award of 50,000 shares.

Get alerted when insiders trade OVID

Email address

Loading company data...

Loading company details...